-
1
-
-
0028987883
-
Macrophages and inflammatory mediators in tissue injury
-
Laskin, D. L., and K. J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:655.
-
(1995)
Annu. Rev. Pharmacol. Toxicol.
, vol.35
, pp. 655
-
-
Laskin, D.L.1
Pendino, K.J.2
-
3
-
-
0030587817
-
Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production
-
Trepicchio, W., M. Bozza, G. Pedneault, and A. Dorner. 1996. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J. Immunol. 157: 3627.
-
(1996)
J. Immunol.
, vol.157
, pp. 3627
-
-
Trepicchio, W.1
Bozza, M.2
Pedneault, G.3
Dorner, A.4
-
4
-
-
0025889028
-
Interleukin-10 inhibits cytokine production by activated macrophages
-
Fiorentino, D. F., A. Zlotnik, T. R. Mossman, M. Howard, and A. O'Garra. 1991. Interleukin-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
-
(1991)
J. Immunol.
, vol.147
, pp. 3815
-
-
Fiorentino, D.F.1
Zlotnik, A.2
Mossman, T.R.3
Howard, M.4
O'Garra, A.5
-
5
-
-
0023726231
-
Deactivation of macrophages by transforming growth factor β
-
Tsunawaki, S., M. Sporn, A. Ding, and C. F. Nathan. 1988. Deactivation of macrophages by transforming growth factor β. Nature 334:260.
-
(1988)
Nature
, vol.334
, pp. 260
-
-
Tsunawaki, S.1
Sporn, M.2
Ding, A.3
Nathan, C.F.4
-
6
-
-
0031569104
-
IL-13 protects mice from LPS-induced lethal endotoxemia
-
Muchamuel, T., S. Menon, P. Pisacane, M. C. Howard, and D. A. Cockayne. 1997. IL-13 protects mice from LPS-induced lethal endotoxemia. J. Immunol. 158:2898.
-
(1997)
J. Immunol.
, vol.158
, pp. 2898
-
-
Muchamuel, T.1
Menon, S.2
Pisacane, P.3
Howard, M.C.4
Cockayne, D.A.5
-
7
-
-
0029994920
-
Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs
-
Ganea, D. 1996. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6:61.
-
(1996)
Adv. Neuroimmunol.
, vol.6
, pp. 61
-
-
Ganea, D.1
-
9
-
-
2642701709
-
Vasoactive intestinal peptide and pituitary adenylale cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages
-
Martinez, C. M. Delgado, D. Pozo, J. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1998. Vasoactive intestinal peptide and pituitary adenylale cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J. Leukocyte Biol. 63:591.
-
(1998)
J. Leukocyte Biol.
, vol.63
, pp. 591
-
-
Martinez, C.1
Delgado, M.2
Pozo, D.3
Leceta, J.4
Calvo, J.R.5
Ganea, D.6
Gomariz, R.P.7
-
10
-
-
0030560659
-
Differential effects of gastrin-releasing peptide, neuropeptide Y, Somatostatin and vasoactive intestinal peptide on interleukin-1β, interleukin-6 and tumor necrosis factor-α production by whole blood cells from healthy young and old subjects
-
Hernanz, A., E. Tato, M. De la Fuente, E. De Miguel, and F. Amalich. 1996. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1β, interleukin-6 and tumor necrosis factor-α production by whole blood cells from healthy young and old subjects. J. Neuroimmunol. 71:25.
-
(1996)
J. Neuroimmunol.
, vol.71
, pp. 25
-
-
Hernanz, A.1
Tato, E.2
De La Fuente, M.3
De Miguel, E.4
Amalich, F.5
-
11
-
-
0031892714
-
The vasoactive intestinal peptide analogue R025-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes
-
Dewit, D., P. Gourlet, Z. Amraoui, P. Vertongen, F. Willems, P. Robberecht, and M. Goldman. 1998. The vasoactive intestinal peptide analogue R025-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes. Immunol. Lett. 60:57.
-
(1998)
Immunol. Lett.
, vol.60
, pp. 57
-
-
Dewit, D.1
Gourlet, P.2
Amraoui, Z.3
Vertongen, P.4
Willems, F.5
Robberecht, P.6
Goldman, M.7
-
12
-
-
0008894590
-
VIP and PACAP protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6
-
In press
-
Delgado, M., C. Martinez, D. Pozo, J. R. Calvo, J. Leceta, D. Ganea, and R. P. Gomariz. 1999. VIP and PACAP protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J. Immunol. In press.
-
(1999)
J. Immunol.
-
-
Delgado, M.1
Martinez, C.2
Pozo, D.3
Calvo, J.R.4
Leceta, J.5
Ganea, D.6
Gomariz, R.P.7
-
13
-
-
0001585265
-
Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP)
-
Harmar, A. J., A. Arimura, I. Gozes, L. Journot, M. Laburthe, J. R. Pisegna, S. R. Rawlings, P. Robberecht, S. I. Said, S. P. Sreedharan, et al. 1999. Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP). Pharmacol. Rev. 50:625.
-
(1999)
Pharmacol. Rev.
, vol.50
, pp. 625
-
-
Harmar, A.J.1
Arimura, A.2
Gozes, I.3
Journot, L.4
Laburthe, M.5
Pisegna, J.R.6
Rawlings, S.R.7
Robberecht, P.8
Said, S.I.9
Sreedharan, S.P.10
-
14
-
-
0030027778
-
Pituitary adenylate cyclase activating polypeptide and PACAP/vasoactive intestinal polypeptidc receptors: Actions on the anterior pituitary gland
-
Rawlings, S. R., and M. Hezareh. 1996. Pituitary adenylate cyclase activating polypeptide and PACAP/vasoactive intestinal polypeptidc receptors: actions on the anterior pituitary gland. Endocr. Rev. 17:4.
-
(1996)
Endocr. Rev.
, vol.17
, pp. 4
-
-
Rawlings, S.R.1
Hezareh, M.2
-
15
-
-
0025756840
-
Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages
-
Segura, J. J., J. M. Guerrero, R. Goberna, and J. R. Calvo. 1991. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Regul. Pept. 33:133.
-
(1991)
Regul. Pept.
, vol.33
, pp. 133
-
-
Segura, J.J.1
Guerrero, J.M.2
Goberna, R.3
Calvo, J.R.4
-
16
-
-
0029949954
-
Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages
-
Delgado, M., D. Pozo, C. Martinez, E. Garrido, J. Leceta, J. R. Calvo, and R. P. Gomariz. 1996. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages. Regul. Pept. 62:161.
-
(1996)
Regul. Pept.
, vol.62
, pp. 161
-
-
Delgado, M.1
Pozo, D.2
Martinez, C.3
Garrido, E.4
Leceta, J.5
Calvo, J.R.6
Gomariz, R.P.7
-
17
-
-
0031566053
-
Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor in rat peritoneal macrophages
-
Pozo, D., M. Delgado, C. Martinez, R. P. Gomariz, J. M. Guerrero, and J. R. Calvo. 1997. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor in rat peritoneal macrophages. Biochim. Biophys. Acta 1359:250.
-
(1997)
Biochim. Biophys. Acta
, vol.1359
, pp. 250
-
-
Pozo, D.1
Delgado, M.2
Martinez, C.3
Gomariz, R.P.4
Guerrero, J.M.5
Calvo, J.R.6
-
18
-
-
0024408824
-
Two types of mouse T helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones
-
Florentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J. Exp. Med. 170:2081.
-
(1989)
J. Exp. Med.
, vol.170
, pp. 2081
-
-
Florentino, D.F.1
Bond, M.W.2
Mosmann, T.R.3
-
19
-
-
0026000892
-
IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II histocompatibility complex expression
-
de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II histocompatibility complex expression. J. Exp. Med. 174:915.
-
(1991)
J. Exp. Med.
, vol.174
, pp. 915
-
-
De Waal Malefyt, R.1
Haanen, J.2
Spits, H.3
Roncarolo, M.G.4
Te Velde, A.5
Figdor, C.6
Johnson, K.7
Kastelein, R.8
Yssel, H.9
De Vries, J.E.10
-
20
-
-
0026094306
-
Inlerleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
-
de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Inlerleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
-
(1991)
J. Exp. Med.
, vol.174
, pp. 1209
-
-
De Waal Malefyt, R.1
Abrams, J.2
Bennett, B.3
Figdor, C.G.4
De Vries, J.E.5
-
21
-
-
0028786539
-
Lipopolysaccharide-induced interleukin-10 in mice: Role of endogenous tumor necrosis factor-α
-
Barsig, J., S. Kusters, K. Vogt, H. D. Volk, G. Tiegs, and A. Wendel. 1995. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur. J. Immunol. 25:2888.
-
(1995)
Eur. J. Immunol.
, vol.25
, pp. 2888
-
-
Barsig, J.1
Kusters, S.2
Vogt, K.3
Volk, H.D.4
Tiegs, G.5
Wendel, A.6
-
22
-
-
0025889036
-
Macrophage deactivation by interleukin 10
-
Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
-
(1991)
J. Exp. Med.
, vol.174
, pp. 1549
-
-
Bogdan, C.1
Vodovotz, Y.2
Nathan, C.3
-
23
-
-
0027240219
-
Interleukin 10 inhibits human IFNγ production by suppressing natural killer cell stimulatory factor IL-12 synthesis in accessory cells
-
D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 inhibits human IFNγ production by suppressing natural killer cell stimulatory factor IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
-
(1993)
J. Exp. Med.
, vol.178
, pp. 1041
-
-
D'Andrea, A.1
Aste-Amezaga, M.2
Valiante, N.M.3
Ma, X.4
Kubin, M.5
Trinchieri, G.6
-
24
-
-
0028365152
-
IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells
-
Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Bilah. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153:811.
-
(1994)
J. Immunol.
, vol.153
, pp. 811
-
-
Wang, P.1
Wu, P.2
Siegel, M.I.3
Egan, R.W.4
Bilah, M.M.5
-
25
-
-
0032526338
-
Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10
-
Aste-Amezaga, M., X. Ma, A. Sartoiri, and G. Trinchieri. 1998. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160: 5936.
-
(1998)
J. Immunol.
, vol.160
, pp. 5936
-
-
Aste-Amezaga, M.1
Ma, X.2
Sartoiri, A.3
Trinchieri, G.4
-
26
-
-
0029935847
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes
-
Martinez, C., M. Delgado, R. P. Gomariz, D. Ganea. 1996. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156:4128.
-
(1996)
J. Immunol.
, vol.156
, pp. 4128
-
-
Martinez, C.1
Delgado, M.2
Gomariz, R.P.3
Ganea, D.4
-
27
-
-
0026549323
-
Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes
-
Kim, J. M., C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. A. Khan, and K. W. Moore. 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148:3618.
-
(1992)
J. Immunol.
, vol.148
, pp. 3618
-
-
Kim, J.M.1
Brannan, C.I.2
Copeland, N.G.3
Jenkins, N.A.4
Khan, T.A.5
Moore, K.W.6
-
28
-
-
0026506870
-
Ly-1 B (B-1) cells are the main source of B-cell derived interleukin-10
-
O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B-cell derived interleukin-10. Eur. J. Immunol. 22:711.
-
(1992)
Eur. J. Immunol.
, vol.22
, pp. 711
-
-
O'Garra, A.1
Chang, R.2
Go, N.3
Hastings, R.4
Haughton, G.5
Howard, M.6
-
29
-
-
0031418036
-
Development of high affinity selective VIP1 receptor agonists
-
Gourlet, P., A. Vandermeers, P. Vertongen, J. Ratche, P. De Neef, J. Cnudde, M. Waelbroeck, and P. Robberecht. Development of high affinity selective VIP1 receptor agonists. Peptides 18:1539-1545.
-
Peptides
, vol.18
, pp. 1539-1545
-
-
Gourlet, P.1
Vandermeers, A.2
Vertongen, P.3
Ratche, J.4
De Neef, P.5
Cnudde, J.6
Waelbroeck, M.7
Robberecht, P.8
-
30
-
-
0030974306
-
The long-acting vasoactive intestinal polypeplide agonist RO25-1553 is highly selective of the VIP2 receptor subclass
-
Gourlet, P., P. Vertongen, A. Vandermeers, M. C. Vandermmers-Piret, J. Rathe, P. De Neef, M. Waelbroeck, and P. Robberecht. 1997. The long-acting vasoactive intestinal polypeplide agonist RO25-1553 is highly selective of the VIP2 receptor subclass. Peptides 18:403.
-
(1997)
Peptides
, vol.18
, pp. 403
-
-
Gourlet, P.1
Vertongen, P.2
Vandermeers, A.3
Vandermmers-Piret, M.C.4
Rathe, J.5
De Neef, P.6
Waelbroeck, M.7
Robberecht, P.8
-
31
-
-
0031030207
-
Maxadilan, the vasodilator peptide from sand flies, is a specific pituitary adenylate cyclase activating peptide type 1 receptor agonist
-
Moro, O., and E. A. Lemer. 1996. Maxadilan, the vasodilator peptide from sand flies, is a specific pituitary adenylate cyclase activating peptide type 1 receptor agonist. J. Biol. Chem. 271:966.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 966
-
-
Moro, O.1
Lemer, E.A.2
-
32
-
-
0028885561
-
Fragments of the pituitary adenylatc cyclase-activating polypeptide discriminate between type I and II recombinant receptors
-
Gourlet, P., M. C. Vandermeers-Piret, J. Rathe, P. De Neef, and P. Robberecht. 1995. Fragments of the pituitary adenylatc cyclase-activating polypeptide discriminate between type I and II recombinant receptors. Eur. J. Pharmacol. 287:7.
-
(1995)
Eur. J. Pharmacol.
, vol.287
, pp. 7
-
-
Gourlet, P.1
Vandermeers-Piret, M.C.2
Rathe, J.3
De Neef, P.4
Robberecht, P.5
-
33
-
-
0031427346
-
In vitro properties of a high affinity selective antagonist of the VIP1 receptor
-
Gourlet, P., P. De Neef, J. Cnudde, M. Waelbroeck, and P. Robberecht. 1997. In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Peptides 18:1555.
-
(1997)
Peptides
, vol.18
, pp. 1555
-
-
Gourlet, P.1
De Neef, P.2
Cnudde, J.3
Waelbroeck, M.4
Robberecht, P.5
-
34
-
-
0024550448
-
Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
-
Kobayashi, E., H. Nakno, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548.
-
(1989)
Biochem. Biophys. Res. Commun.
, vol.159
, pp. 548
-
-
Kobayashi, E.1
Nakno, H.2
Morimoto, M.3
Tamaoki, T.4
-
35
-
-
0025248571
-
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase. N-[2-(p-bromociannamylamino)ethyl]-5-isoquinoleinsulfonamide (H89), of PC12D pheochromocytoma cells
-
Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase. N-[2-(p-bromociannamylamino)ethyl]-5-isoquinoleinsulfonamide (H89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267.
-
(1990)
J. Biol. Chem.
, vol.265
, pp. 5267
-
-
Chijiwa, T.1
Mishima, A.2
Hagiwara, M.3
Sano, M.4
Hayashi, K.5
Inoue, T.6
Naito, K.7
Toshioka, T.8
Hidaka, H.9
-
36
-
-
0021179765
-
Forskolin stimulates adenylate cyclase in human colonic crypts: Interaction with VIP
-
Boige, N., B. Aminaroff, A. Munk, and M. Laburthe. 1984. Forskolin stimulates adenylate cyclase in human colonic crypts: interaction with VIP. Eur. J. Pharmacol. 101:111.
-
(1984)
Eur. J. Pharmacol.
, vol.101
, pp. 111
-
-
Boige, N.1
Aminaroff, B.2
Munk, A.3
Laburthe, M.4
-
37
-
-
0028957419
-
Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs
-
Platzer, C., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1995. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol 7:517.
-
(1995)
Int. Immunol
, vol.7
, pp. 517
-
-
Platzer, C.1
Meisel, C.2
Vogt, K.3
Platzer, M.4
Volk, H.D.5
-
38
-
-
0028109394
-
Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
-
Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi. 1995. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180: 2365.
-
(1995)
J. Exp. Med.
, vol.180
, pp. 2365
-
-
Strassmann, G.1
Patil-Koota, V.2
Finkelman, F.3
Fong, M.4
Kambayashi, T.5
-
39
-
-
0028841166
-
IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury
-
Arai, T., K. Hiromatsu, N. Kobayashi, M. Takano, H. Ishida, Y. Nimura, and Y. Yoshikai. 1995. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155:5743.
-
(1995)
J. Immunol.
, vol.155
, pp. 5743
-
-
Arai, T.1
Hiromatsu, K.2
Kobayashi, N.3
Takano, M.4
Ishida, H.5
Nimura, Y.6
Yoshikai, Y.7
-
40
-
-
0028843980
-
Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages
-
Kambayashi, T., C. O. Jacob, D. Zhou, N. Mazurek, M. Fong, and G. Strassmann. 1995. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 155:4909.
-
(1995)
J. Immunol.
, vol.155
, pp. 4909
-
-
Kambayashi, T.1
Jacob, C.O.2
Zhou, D.3
Mazurek, N.4
Fong, M.5
Strassmann, G.6
-
41
-
-
0029901533
-
The significance of vasoactive intestinal peptide (VIP) in immunomodulation
-
Bellinger, D. L., D. Lorton, S. Brouxhon, S. Felten, and D. L. Felten. 1996. The significance of vasoactive intestinal peptide (VIP) in immunomodulation. Adv. Neuroimmunol. 6:5.
-
(1996)
Adv. Neuroimmunol.
, vol.6
, pp. 5
-
-
Bellinger, D.L.1
Lorton, D.2
Brouxhon, S.3
Felten, S.4
Felten, D.L.5
-
42
-
-
0003131711
-
Vasoactive intestinal peptide
-
D. Raenburn and M. A. Giembycz, eds. Birkhauser Verlag Basel, Switzerland
-
Said, S. I. 1985. Vasoactive intestinal peptide. In: Airways Smooth Muscle: Peptide Receptors, Ion Channels, and Signal Transduction. D. Raenburn and M. A. Giembycz, eds. Birkhauser Verlag Basel, Switzerland, p. 87.
-
(1985)
Airways Smooth Muscle: Peptide Receptors, Ion Channels, and Signal Transduction
, pp. 87
-
-
Said, S.I.1
-
43
-
-
0025260903
-
Interleukin 6: An overview
-
Van Snick, J. 1990. Interleukin 6: an overview. Annu. Rev. Immunol. 8:253.
-
(1990)
Annu. Rev. Immunol.
, vol.8
, pp. 253
-
-
Van Snick, J.1
-
44
-
-
0026717674
-
The pathophysiology of tumor necrosis factor
-
Vassali, P. 1992. The pathophysiology of tumor necrosis factor. Annu. Rev. Immunol. 10:411.
-
(1992)
Annu. Rev. Immunol.
, vol.10
, pp. 411
-
-
Vassali, P.1
-
45
-
-
0008228191
-
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors
-
Gourlet, P., J.-P. Vilardaga, P. De Neef, M. Waelbroeck, A. Vandermeers, and P. Robberecht. 1996. The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides 17:825.
-
(1996)
Peptides
, vol.17
, pp. 825
-
-
Gourlet, P.1
Vilardaga, J.-P.2
De Neef, P.3
Waelbroeck, M.4
Vandermeers, A.5
Robberecht, P.6
-
46
-
-
0025865918
-
Structure-activity studies of vasoactive intestinal polypeptide
-
O'Donnell, M., R. J. Garippa, N. C. O'Neill, D. R. Bolin, and J. M. Cottrell, 1991. Structure-activity studies of vasoactive intestinal polypeptide. J. Biol. Chem. 266:6389.
-
(1991)
J. Biol. Chem.
, vol.266
, pp. 6389
-
-
O'Donnell, M.1
Garippa, R.J.2
O'Neill, N.C.3
Bolin, D.R.4
Cottrell, J.M.5
-
47
-
-
0032553421
-
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun
-
Delgado, M., E. J. Munoz-Elias, Y. Kan, I. Gozes, M. Fridkin, D. E. Brenneman, R. P. Gomariz, and D. Ganea. 1998. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun. J. Biol. Chem. 273:31427.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 31427
-
-
Delgado, M.1
Munoz-Elias, E.J.2
Kan, Y.3
Gozes, I.4
Fridkin, M.5
Brenneman, D.E.6
Gomariz, R.P.7
Ganea, D.8
-
48
-
-
0029883204
-
Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism
-
Wang, H.-Y., Z Xin., H. Tang, and D. Ganea. 1996. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism. J. Immunol. 156:3243.
-
(1996)
J. Immunol.
, vol.156
, pp. 3243
-
-
Wang, H.-Y.1
Xin, Z.2
Tang, H.3
Ganea, D.4
-
49
-
-
0031930674
-
Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.A cells: Role of protein synthesis and protein kinases
-
Muller, A., B. Lutz-Bucher, P. Kienlen-Campard, B. Koch, and J. P. Loeffler. 1998. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases. J. Neurochem. 70:1431.
-
(1998)
J. Neurochem.
, vol.70
, pp. 1431
-
-
Muller, A.1
Lutz-Bucher, B.2
Kienlen-Campard, P.3
Koch, B.4
Loeffler, J.P.5
-
50
-
-
0030891325
-
Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II. Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide
-
Aoki, Y., Y. Iwasaki, M. Katahira, Y. Oiso, and H. Saito. 1997. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II. Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Endocrinology 138:1930.
-
(1997)
Endocrinology
, vol.138
, pp. 1930
-
-
Aoki, Y.1
Iwasaki, Y.2
Katahira, M.3
Oiso, Y.4
Saito, H.5
-
51
-
-
0029985034
-
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: Immunocytochemical and immunochemical evidence
-
Schomerus, C., E. Maronde, E. Laedtke, and H. W. Korf. 1996. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce phosphorylation of the transcription factor CREB in subpopulations of rat pinealocytes: immunocytochemical and immunochemical evidence. Cell. Tissue Res. 286:305.
-
(1996)
Cell. Tissue Res.
, vol.286
, pp. 305
-
-
Schomerus, C.1
Maronde, E.2
Laedtke, E.3
Korf, H.W.4
-
52
-
-
0029050265
-
C-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes
-
Hsueh, Y.-P., and M.-Z. Lai. 1995. C-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J. Biol. Chem. 270:18094.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 18094
-
-
Hsueh, Y.-P.1
Lai, M.-Z.2
-
53
-
-
0027408695
-
Interleukin 10 protects mice from lethal endotoxemia
-
Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
-
(1993)
J. Exp. Med.
, vol.177
, pp. 1205
-
-
Howard, M.1
Muchamuel, T.2
Andrade, S.3
Menon, S.4
-
54
-
-
0031569098
-
CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression
-
Wang, R., Q. Fang, L. Zhang, L. Radvany, A. Sharma, N. Noben-Trauth, G. B. Mills, and Y. Shi. 1997. CD28 ligation prevents bacterial toxin-induced septic shock in mice by inducing IL-10 expression. J. Immunol. 158:2856.
-
(1997)
J. Immunol.
, vol.158
, pp. 2856
-
-
Wang, R.1
Fang, Q.2
Zhang, L.3
Radvany, L.4
Sharma, A.5
Noben-Trauth, N.6
Mills, G.B.7
Shi, Y.8
-
55
-
-
0031568387
-
Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia
-
van der Poll, T., P M. Jansen, W. J. Montegut, C. C. Braxton, S. E. Calvano, S, A. Stackpole, S. R. Smith, S. W. Swanson, C. E. Hack, S. F. Lowry, et al. 1997. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1971.
-
(1997)
J. Immunol.
, vol.158
, pp. 1971
-
-
Van Der Poll, T.1
Jansen, P.M.2
Montegut, W.J.3
Braxton, C.C.4
Calvano, S.E.5
Stackpole, S.A.6
Smith, S.R.7
Swanson, S.W.8
Hack, C.E.9
Lowry, S.F.10
-
56
-
-
0027968670
-
Interleukin 10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1
-
Tumpey, T. M., V. M. Elner, S. Chen, J. E. Oakes, and R. N. Lausch. 1994. Interleukin 10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J. Immunol. 153:2258.
-
(1994)
J. Immunol.
, vol.153
, pp. 2258
-
-
Tumpey, T.M.1
Elner, V.M.2
Chen, S.3
Oakes, J.E.4
Lausch, R.N.5
-
57
-
-
0027508426
-
Protective effects of IL-4, and IL-10 against immune complex induced lung injury
-
Mulligan, M. S., M. L. Jones, A. A. Vaporciyan, M. C. Howard, and P. A. Wood. 1993. Protective effects of IL-4, and IL-10 against immune complex induced lung injury. J. Immunol. 151:5666.
-
(1993)
J. Immunol.
, vol.151
, pp. 5666
-
-
Mulligan, M.S.1
Jones, M.L.2
Vaporciyan, A.A.3
Howard, M.C.4
Wood, P.A.5
-
58
-
-
0028907439
-
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
-
Schreiber, S., T. Heinig, H. G. Thiele, and A. Raedler. 1995. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108:1434.
-
(1995)
Gastroenterology
, vol.108
, pp. 1434
-
-
Schreiber, S.1
Heinig, T.2
Thiele, H.G.3
Raedler, A.4
-
59
-
-
0017405831
-
The newer gut hormone: Cellular sources, physiology, pathology, and clinical aspects
-
Pearse, A. G. E., J. M. Polak, and S. R. Bloom. 1977. The newer gut hormone: cellular sources, physiology, pathology, and clinical aspects. Gastroenterology 72:746.
-
(1977)
Gastroenterology
, vol.72
, pp. 746
-
-
Pearse, A.G.E.1
Polak, J.M.2
Bloom, S.R.3
-
60
-
-
0019787357
-
Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats, and human subjects
-
Dey, R. D., W. A. Shannon, and S. I. Said. 1981. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats, and human subjects. Cell Tissue Res. 220:231.
-
(1981)
Cell Tissue Res.
, vol.220
, pp. 231
-
-
Dey, R.D.1
Shannon, W.A.2
Said, S.I.3
-
61
-
-
0027278121
-
Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: Evidence for regulation of vasoactive intestinal peptide release by nitric oxide
-
Grider, J. R., and J.-G. Jin. 1993. Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience 54:521.
-
(1993)
Neuroscience
, vol.54
, pp. 521
-
-
Grider, J.R.1
Jin, J.-G.2
-
62
-
-
0029861586
-
Regulation of VIP release from rat enteric nerve terminals: Evidence for a stimulatory effect of NO
-
Allescher, H. D., M. Kurjak, A. Huber, P. Trudrung, and V. Schusdziarra. 1996. Regulation of VIP release from rat enteric nerve terminals: evidence for a stimulatory effect of NO. Am. J. Physiol. 271:G568.
-
(1996)
Am. J. Physiol.
, vol.271
-
-
Allescher, H.D.1
Kurjak, M.2
Huber, A.3
Trudrung, P.4
Schusdziarra, V.5
-
63
-
-
0033083302
-
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: In vitro and in vivo studies
-
In press
-
Delgodo, M., D. Pozo, C. Martinez, J. Leceta, J. R. Calvo, D. Genea, and R. P. Gomariz. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies. J. Immunol. 162, In press.
-
(1999)
J. Immunol.
, vol.162
-
-
Delgodo, M.1
Pozo, D.2
Martinez, C.3
Leceta, J.4
Calvo, J.R.5
Genea, D.6
Gomariz, R.P.7
|